Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
505.00    4.50 (0.90%)
Bid:
505.00
Ask:
505.50
Spread: 0.50 (0.099%)
Market Cap: £2.23b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

13 Sep 2017 10:00

Tate & Lyle PLC

Notification of transactions by Person Discharging Managerial Responsibilities and Person Closely Associated with them

Tate & Lyle PLC (the ‘Company’) was informed yesterday that on 12 September 2017 Javed Ahmed, a Person Discharging Managerial Responsibilities, exercised 419,403 nil-cost options over ordinary shares of 25 pence each in the capital of the Company (‘Shares’), in accordance with the ‘Compensatory Award – A’ that was granted to him on 28 October 2009, full details of which are set out in the Annual Report 2009. 197,812 Shares were sold at 661.60 pence per Share on the London Stock Exchange to cover Mr Ahmed’s tax liabilities and sale costs.

Mr Ahmed retained the remaining Shares and subsequently transferred a total of 317,718 Shares to a joint holding with Mrs Ahmed, a person closely associated with him. Mr Ahmed now holds an interest in a total of 3,416,568 Shares in the Company.

The notifications below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Claire-Marie O’GradyCompany Secretary13 September 2017

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Details of PDMR / person closely associated with them (“PCA”)
a) Name Javed Ahmed
2. Reason for the notification
a) Position / status PDMR – Chief Executive
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Exercise of nil-cost options over shares for no consideration
c) Price(s) and

Price(s)

Volume(s)

volume(s)

Nil

419,403

d) Aggregated
information
-- Aggregated volume

419,403

-- Price

Nil

e) Date of the transaction 2017-09-12
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Details of PDMR / person closely associated with them (“PCA”)
a) Name Javed Ahmed
2. Reason for the notification
a) Position / status PDMR – Chief Executive
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Sale of shares to cover tax liabilities and sale costs arising on exercise of options.

c)

Price(s) and Price(s)

Volume(s)

volume(s)

GBP 6.6160

197,812

d) Aggregated
information
-- Aggregated volume 197,812
-- Price

GBP 6.6160

e) Date of the transaction 2017-09-12
f) Place of the transaction London Stock ExchangeXLON

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Details of PDMR / person closely associated with them (“PCA”)
a) Name Javed Ahmed
2. Reason for the notification
a) Position / status PDMR – Chief Executive
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Transfer of shares at nil cost a to joint holding account with Talat Ahmed, Person Closely Associated to Mr Ahmed

c)

Price(s) and

Price(s)

Volume(s)

volume(s)

Nil

317,718

d) Aggregated

information
-- Aggregated volume

317,718

-- Price

Nil

e) Date of the transaction 2017-09-12
f) Place of the transaction London Stock ExchangeXLON

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of PDMR / person closely associated with them (“PCA”)
a) Name Talat Ahmed
2. Reason for the notification
a) Position / status PCA of Javed Ahmed
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Receipt of shares transferred at nil cost held in a joint account with Mr Ahmed

c)

Price(s) and Price(s)

Volume(s)

volume(s)

Nil

317,718

d) Aggregated
information
-- Aggregated volume 317,718
-- Price

Nil

e) Date of the transaction 2017-09-12
f) Place of the transaction London Stock ExchangeXLON

View source version on businesswire.com: http://www.businesswire.com/news/home/20170913005105/en/

Copyright Business Wire 2017

Date   Source Headline
27th Mar 20262:00 pmRNSHolding(s) in Company
13th Mar 20264:00 pmRNSHolding(s) in Company
2nd Mar 20262:00 pmRNSHolding(s) in Company
26th Feb 20267:00 amRNSTrading Statement
23rd Feb 202610:00 amRNSHolding(s) in Company
17th Feb 202612:00 pmRNSHolding(s) in Company
21st Jan 20267:00 amRNSDirectorate change
15th Jan 20269:00 amRNSHolding(s) in Company
12th Jan 202610:00 amRNSHolding(s) in Company
7th Jan 20264:30 pmRNSDirector/PDMR Shareholding
7th Jan 20262:30 pmRNSBlock listing Interim Review
18th Dec 20252:00 pmRNSDirector/PDMR Shareholding
18th Dec 20252:00 pmRNSDirector/PDMR Shareholding
11th Dec 202512:18 pmRNSDirector/PDMR Shareholding
9th Dec 20259:00 amRNSHolding(s) in Company
27th Nov 202510:00 amRNSDirector/PDMR Shareholding
11th Nov 20254:30 pmRNSDirector/PDMR Shareholding
10th Nov 20252:40 pmRNSDirector Declaration
6th Nov 20257:00 amRNSHalf-year Financial Report
5th Nov 20252:15 pmRNSHolding(s) in Company
3rd Nov 20255:00 pmRNSHolding(s) in Company
29th Oct 20252:00 pmRNSHolding(s) in Company
23rd Oct 20254:15 pmRNSHolding(s) in Company
21st Oct 20253:30 pmRNSHolding(s) in Company
16th Oct 202512:00 pmRNSHolding(s) in Company
8th Oct 202512:00 pmRNSHolding(s) in Company
6th Oct 20254:30 pmRNSDirector/PDMR Shareholding
6th Oct 20254:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20254:00 pmRNSDirector/PDMR Shareholding
3rd Oct 202510:00 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSPre-close statement
2nd Sep 20258:00 amRNSTotal Voting Rights
11th Aug 20251:00 pmRNSDirector/PDMR Shareholding
5th Aug 20257:00 amRNSDirector/PDMR Shareholding
1st Aug 202511:00 amRNSTotal Voting Rights
24th Jul 20252:30 pmRNSResult of Annual General Meeting 2025
15th Jul 20251:00 pmRNSDirector/PDMR Shareholding
1st Jul 20253:30 pmRNSBlock listing Interim Review
1st Jul 20257:00 amRNSTate & Lyle Capital Markets Event
13th Jun 20253:00 pmRNSHolding(s) in Company
11th Jun 20254:30 pmRNSDirector/PDMR Shareholding
5th Jun 20252:30 pmRNSAnnual Financial Report and Notice of Meeting 2025
5th Jun 20252:00 pmRNSDirector/PDMR Shareholding
2nd Jun 202512:30 pmRNSTotal Voting Rights
28th May 202512:00 pmRNSDirector/PDMR Shareholding
27th May 202512:00 pmRNSDirector/PDMR Shareholding
23rd May 202510:00 amRNSDirector/PDMR Shareholding
22nd May 20257:00 amRNSFinal Results
14th May 20259:00 amRNSHolding(s) in Company
1st May 20253:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.